Alembic Pharma Stock Hits Upper Circuit After Q2 Profit Surges 81%

Shares of Alembic Pharmaceuticals hit the upper circuit following an impressive 81 percent surge in second-quarter net profit. The robust financial performance significantly boosted investor confidence and trading activity on the stock exchanges. This strong growth highlights the company's solid operational execution during the quarter.